13G INITIAL ANNUAL FILING (FOLD)

Company

AMICUS THERAPEUTICS, INC.

Filed

February 2, 2017

Accession Number

0000053417-17-000009

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →